289 related articles for article (PubMed ID: 26192153)
1. Association between Glaucoma Medication Usage and Dry Eye in Taiwan.
Chen HY; Lin CL; Tsai YY; Kao CH
Optom Vis Sci; 2015 Sep; 92(9):e227-32. PubMed ID: 26192153
[TBL] [Abstract][Full Text] [Related]
2. Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study.
Chen HY; Lin CL; Kao CH
Medicine (Baltimore); 2019 Jan; 98(4):e14128. PubMed ID: 30681574
[TBL] [Abstract][Full Text] [Related]
3. The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007.
Lin JC
J Glaucoma; 2015; 24(5):364-71. PubMed ID: 26039384
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T
Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224
[TBL] [Abstract][Full Text] [Related]
5. Side effects of glaucoma medications.
Detry-Morel M
Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
[TBL] [Abstract][Full Text] [Related]
6. The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.
Kocabeyoglu S; Mocan MC; Irkec M
Acta Ophthalmol; 2014 Nov; 92(7):e592-3. PubMed ID: 24774884
[No Abstract] [Full Text] [Related]
7. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database.
Lafuma A; Berdeaux G
Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015
[TBL] [Abstract][Full Text] [Related]
8. New glaucoma medications in the geriatric population: efficacy and safety.
Novack GD; O'Donnell MJ; Molloy DW
J Am Geriatr Soc; 2002 May; 50(5):956-62. PubMed ID: 12028187
[TBL] [Abstract][Full Text] [Related]
9. Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan.
Chen YY; Lai YJ; Yen YF; Shen YC; Wang CY; Liang CY; Lin KH; Fan LW
BMJ Open; 2018 Nov; 8(11):e022987. PubMed ID: 30397009
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Tanna AP; Lin AB
Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacology aspects of glaucoma].
Alm A; Berggren L
Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
[TBL] [Abstract][Full Text] [Related]
12. [Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years].
Liang YB; Wu HX; Liao N; Li M; Zhang Q; Wang PJ; Zheng JW; Fang AW; Qu J
Zhonghua Yan Ke Za Zhi; 2018 Jul; 54(7):520-525. PubMed ID: 29996614
[No Abstract] [Full Text] [Related]
13. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
Tugushi OA; Shliapuzhnikova AV; Listopadova NA
Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
[No Abstract] [Full Text] [Related]
14. Glaucoma pharmacotherapy: implications for flying fitness.
Lam PM
Aviat Space Environ Med; 2005 Aug; 76(8):786-93. PubMed ID: 16110697
[TBL] [Abstract][Full Text] [Related]
15. Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017.
Yu L; Ding K; Luo L; Yu Z
PLoS One; 2020; 15(1):e0227595. PubMed ID: 31929565
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
Tanna AP; Rademaker AW; Stewart WC; Feldman RM
Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
[TBL] [Abstract][Full Text] [Related]
17. Association between topical prostaglandin analog use and development of choroidal neovascular membranes in patients with concurrent glaucoma and age-related macular degeneration.
Scherer WJ
J Ocul Pharmacol Ther; 2006 Apr; 22(2):139-44. PubMed ID: 16722800
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical management of the childhood glaucomas.
Talbot AW; Russell-Eggitt I
Expert Opin Pharmacother; 2000 May; 1(4):697-711. PubMed ID: 11249511
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological therapy for glaucoma: a review.
Hoyng PF; van Beek LM
Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828
[TBL] [Abstract][Full Text] [Related]
20. Management of glaucoma: focus on pharmacological therapy.
Marquis RE; Whitson JT
Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
